Biorestorative Therapies (BRTX)
(Delayed Data from NSDQ)
$1.45 USD
+0.02 (1.40%)
Updated Aug 8, 2025 03:59 PM ET
After-Market: $1.44 -0.01 (-0.69%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Biorestorative Therapies, Inc. has a market cap of $10.73M, which represents its share price of $1.43 multiplied by its outstanding shares number of 7.50M. As a small-cap company, BRTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BRTX 1.45 +0.02(1.40%)
Will BRTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BRTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BRTX
Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates
BRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Lags Revenue Estimates
Stoke Therapeutics, Inc. (STOK) Tops Q1 Earnings and Revenue Estimates
Coherus BioSciences (CHRS) Reports Q1 Loss, Lags Revenue Estimates
Other News for BRTX
BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference ...
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 ...
BioRestorative Therapies (BRTX) Initiates $2 Million Stock Buyback Program | BRTX Stock News
BioRestorative Announces Share Repurchase Program | BRTX Stock News
BioRestorative Therapies announces share repurchase program; shares gain over 8%